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Summary 
In this work a gene coding for a novel self-sufficient class VII cytochrome P450 
monooxygenase (CYP116B5) was identified in the genome of Acinetobacter 
radioresistens S13 that allows it to grow on media supplemented with medium (C14, 
C16) and long (C24, C36) chain alkanes as the sole energy source. Phylogenetic 
analysis of the N- and C-terminal domains of CYP116B5 suggests an evolutionary 
model of cyp116b5 gene: a plasmid-mediated horizontal gene transfer probably 
occurred from the donor bacterium Rhodococcus jostii RHA1 to the receiving A. 
radioresistens S13. This event was followed by gene fusion and a subsequent 
integration of the new fused gene in A. radioresistens chromosome. 
Heterologous expression of CYP116B5 in E. coli BL21, together with the A. 
radioresistens Baeyer-Villiger monooxygenase, allowed the recombinant bacteria to 
grow on long- and medium-chain alkanes, showing that CYP116B5 is involved in the 
first step of terminal oxidation of medium-chain alkanes overlapping AlkB and in the 
first step of sub-terminal oxidation of long-chain alkanes. Furthermore, it was also 
demonstrated for the first time that CYP116B5 is a naturally self-sufficient 
cytochrome P450 consisting of a haem domain (aa 1-392) involved in the oxidation 
step of n-alkanes degradation, and its reductase domain (aa 444-758) comprising the 
NADPH-, FMN- and [2Fe2S]-binding sites. To our knowledge CYP116B5 is the first 
member of this class to have its natural substrate and function identified. 
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Introduction 
Bacterial oxidation of n-alkanes is a very common phenomenon in soil and water 
(Bühler and Schindler, 1984) and it is a major process in geochemical terms. Bacterial 
monooxygenases (MOs) are relevant to biogeochemistry (Hakemian and Rosenzweig, 
2007), bioremediation (Wood, 2008) and biocatalysis (Leak et al, 2009). Based on 
cofactor and cellular location, five MO superfamilies can be distinguished in bacteria: 
soluble flavin-binding monooxygenases (FMO) (van Berkel et al, 2006), cytochromes 
P450 (CYP) (Bernhardt, 2006), soluble diiron monooxygenases (SDIMO) (Notomista 
et al, 2003), alkane hydroxylases (pAH/AlkB) (van Beilen and Funhoff, 2007) and 
copper-containing proteins (Lieberman and Rosenzweig, 2004). There are overlaps in 
the physiological substrate range of bacterial MOs (van Beilen and Funhoff, 2007): 
FMO and CYP enzymes act on alkanes, aromatics and heterocyclics, AlkB-type MO 
is typically involved in oxidation of liquid alkanes (C5–C16), SDIMOs act on small 
gaseous hydrocarbons (C1–C4 alkanes and alkenes) and single-ring aromatics (e.g. 
phenol, toluene), and copper MOs specifically oxidize small compounds, such as 
methane and ammonia. 
Cytochromes P450 are a large family of haem-thiolate enzymes found in all biological 
kingdoms and they catalyze a wide range of oxidative reactions. Substrates include 
natural compounds, such as steroids, fatty acids, pheromones, leukotrienes and 
prostaglandins, as well as xenobiotics such as drugs and carcinogens (Dodhia and 
Gilardi, 2009). Their primary chemical reaction is the monooxygenation of the 
substrate involving the activation of molecular oxygen, followed by the insertion of a 
single atom of oxygen into an organic substrate with concomitant reduction of the 
other oxygen atom to water. Electron equivalents are supplied by NAD(P)H through 
an electron transfer chain involving different redox partners, the nature of which is 
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used to classify cytochromes P450 into ten classes (Hannemann et al, 2007; Sadeghi 
and Gilardi, 2013).  
Despite the identification and cloning of an enormous number of cytochromes P450 
from bacterial sources, there have been very few examples that do not fall into the 
general class I category of enzymes. An example of exception is the soluble fatty acid 
hydroxylase from Bacillus megaterium, P450-BM3, that is a catalytically self-
sufficient single-polypeptide enzyme containing haem, FAD and FMN in equimolar 
ratios and requiring NADPH as a source of electrons (Narhi and Fulco, 1986). Two 
further P450 enzymes (CYP102A2 and CYP102A3) from Bacillus subtilis displaying 
an overall organization similar to that of P450-BM3 have also been identified 
(Gustafsson, 2000). Recently, a membrane-bound eukaryotic counterpart of P450-
BM3 has been cloned from Fusarium oxysporum (Kitazume et al, 2000). A distinctive 
type of P450–redox partner fusion system was identified from genome analysis of 
pathogenic Burkholderia species, the heavy metal-tolerant bacterium 
Cupriavidus metallidurans CH34 and Rhodococcus sp. NCIMB 9784 (De Mot and 
Parret, 2002). In this system, P450 of undefined structure and substrate specificity, 
classified in the CYP116B P450 family, are fused to a reductase module with an 
aminoacid sequence resembling that of Burkholderia cepacia phthalate dioxygenase 
reductase (PDOR), an enzyme that provides electrons to phthalate dioxygenase (PDO) 
to enable this enzyme to oxygenate phthalate as a carbon source for growth (Gassner 
et al, 1995). As with P450-BM3, the P450 domain in the novel CYP116–PDOR 
fusion enzymes is fused at the N-terminus of the polypeptide chain. The Rhodococcus 
enzyme from this family (CYP116B2) exhibits P450-like spectral characteristics. 
Genetic dissection of the enzyme enabled the characterization of FMN and 2Fe-2S 
centres in the expressed PDOR module (Roberts et al, 2003; Hunter et al, 2005). 
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CYP116B2 was also shown to have weak activity towards 7-ethoxycoumarin, a 
prototypical fluorescent substrate for the P450 superfamily, but no physiologically 
relevant substrates were identified. 
Bacterial cytochrome P450 systems involved in alkane degradation have been 
reported in Rhodococcus rhodochrous that contains an octane hydroxylating 
cytochrome P450 enzyme (Cardini and Jurtshuk, 1970). Another cytochrome P450 
enzyme involved in alkane hydroxylation was isolated (Muller et al, 1989) and cloned 
from Acinetobacter calcoaceticus EB104 (Maier et al, 2001).  
This paper investigates the presence of cytochrome P450 in Acinetobacter 
radioresistens S13, a bacterium isolated from soil surrounding an activated sludge 
pilot plant near Torino (Italy) (Giunta and Pessione, 1997) that can utilize medium- 
and long-chain alkanes as the sole carbon and energy source (Minerdi et al, 2012). 
We found that it possesses genes coding for terminal alkane hydroxylase (alkB) and a 
Baeyer-Villiger monooxygenase (almA) involved in the initial steps of terminal and 
subterminal oxidation of medium- and long-chain alkanes, respectively. The two 
genes are differentially expressed according to the presence of medium- or long-chain 
alkanes (Minerdi et al, 2012).  
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Results 
Screening for cytochrome P450 genes in A. radioresistens strain S13 
In order to examine the presence of cytochrome P450 alkane hydroxylase in A. 
radioresistens S13, PCR experiments were performed with oligonucleotide primers 
based on the sequence of the P450 gene of A. radioresistens strain SK82. This led to a 
PCR product of 500 bp, a size compatible with the presence of a cytochrome P450 
coding gene. Analysis of the full length nucleotide sequence obtained by a genome-
walking strategy revealed the presence of one complete open reading frame (ORF) of 
2,274 bp, hereinafter referred to as ORF2274. Sequence comparison using the BLAST 
programme (Altschul et al, 1997) against the non-redundant GenBank database 
showed that the amino acid sequence had very low E-values (the probability due to 
chance that there is another alignment with a similarity greater than the given score), 
when aligned with bacterial cytochrome P450 monooxygenases. 
Phylogenetic and amino acid sequence analysis  
A CLUSTALW multi-alignment was followed by visual inspection and manual 
editing of the A. radioresistens S13 P450 sequence. Phylogenetic tree of the whole 
amino acid sequence was inferred from the selected sequences by the Distant Matrix 
method. Results placed the sequence under investigation within the self-sufficient 
class VII P450 monooxygenases (Roberts et al, 2003) (Fig. 1). 
The ORF2274 encodes a protein of 758 amino acids, with predicted molecular mass 
of 85,700 Da;  A ClustalW multi-alignment of its amino acid sequence with 
cytochrome P450 sequences available in databases was used to identify conserved 
regions and to detect the degrees of sequence similarity and identity between the A. 
radioresistens S13 P450 protein and orthologous proteins. The sequence homology 
search using the aminoacid sequence coded by ORF2274 revealed significant 
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homology with the self-sufficient class VII cytochrome P450 (Roberts et al, 2002). 
Comparison of the translated sequence from residue 1 to 392 with those of the 
SWISSPROT database shows a sequence homology of 62 % with the haem domain of 
CYP116B2 from Rhodococcus sp. NCIMB 9784 (Fig. 2A). This indicates that the A. 
radioresistens protein under investigation is a new member of CYP116B subfamily 
and the new enzyme was named CYP116B5 (http://drnelson.uthsc.edu/bacteria.html). 
The sequence 367FGYGAHQCMG (Fig. 2A, red) matches the PROSITE consensus 
motif ([F/W][S/G/N/H]X[G/D]X[R/H/P/T]XC[L/I/V/M/F/A/P][G/A/D]) for 
cytochrome P450 enzymes, spanning the hydrophobic haem-ligand pocket showing 
that the sequence between amino acids 1-392 corresponds to a haem binding domain 
and the residue C374 is predicted to be the heam-iron fifth ligand. Another consensus 
motif is the 263AAHETT (Fig. 2A, green) that corresponds to the putative oxygen 
binding sequence (Roberts et al, 2002). 
The C-terminal portion from residue 444 to 758 of the translation product of the 
CYP116B5 gene shows sequence homology to reductase proteins. An alignment of 
this sequence with those of two representative reductase subunits of oxygenases from 
various sources is shown in Figure 2B. The C-terminal region of proteins of known 
function can be subdivided into three distinct functional parts: a FMN-binding 
domain, a NADH-binding domain and a ferredoxin-like [2Fe2S] domain. The 
sequence 518SRGGS (Fig. 2B, grey) corresponds to the consensus motif [G/S]RGGS 
involved in binding the phosphate group of FMN. The fingerprint sequence GXGXXP 
for NADH binding, 559GIGITP (Fig. 2B, purple) is a region highly conserved within 
the representative members of this class of enzymes. The crystal structure of the 
closely related phthalate dioxygenase reductase indicates that the proline residue in 
this sequence contacts the bound nicotinamide (Correll et al, 1992). Another signature 
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sequence is represented by the four highly conserved cysteine residues that are 
marked by asterisks in Figure 2B. Three of the four cysteines are closely clustered in 
the primary amino acid sequence 708CTEGLCGSC, and it conforms to the PROSITE 
consensus motif CXX[G/A]XC[G/A/S/T]XC of a [2Fe2S] ferredoxin (Roberts et al, 
2002). Taken together these results indicate that CYP116B5 is a class VII 
catalytically self-sufficient cytochrome P450 enzyme composed of a haem (residues 
1-392) and a reductase domain (residues 444-758), the haem is ligated to C374 and 
the reductase domain comprises NADH and FMN binding sites, as well as a [2Fe2S] 
cluster involving cysteine residues 708, 713, 716 and 746. 
A model for the evolution of the CYP116B5 gene 
In order to investigate the evolutionary origin of A. radioresistens S13 cyp116b5 
coding gene, a phylogenetic analysis of the two separate N- and C-terminal domains 
of CYP116B5 was performed. In order to retrieve the most similar sequences the 
amino acid sequences of the two domains were used as a query to probe the protein 
database of completely sequenced proteobacterial genomes with the BLASTP and R-
PSI BLASTP option of BLAST programme. As expected, neighbor joining tree 
positioned the CYP116B5 N-terminus-haem containing domain (N-HD) among class 
I cytochrome P450 monooxygenases but, surprisingly, far away from Acinetobacter 
class I P450s. As shown in Figure 3A, S13-HD clusters together with the class I P450 
(CYP 116) from R. jostii strain RHA1 with a bootstrap value of 99 out of 100.  
The C-terminal domain of CYP116B5 (C-OXD) shows high sequence similarity with 
the reductase domain of several monooxygenases, positioning C-OXD among 2Fe2S-
flavin containing oxidoreductases. Interestingly, C-OXD clusters together with a 
2Fe2S-flavin containing oxidoreductase from R. jostii RHA1, with a bootstrap value 
of 93 out of 100 (Fig. 3B). The gene coding for R. jostii RHA1 oxidoreductase is 
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adjacent to the gene coding for CYP116 of R. jostii RHA1 and both P450 and its 
reductase of this organism are located in the pRHL3 plasmid 
(http://www.ncbi.nlm.nih.gov/nuccore/NC_008271.1). For this reason the 
oxidoreductase of R. jostii is called OXRED116. 
The results obtained from the phylogenetic analysis of the two separate N-HD and C-
OXD domains of CYP116B5, together with the arrangement of the P450 and its 
reductase in the R. jostii and A. radioresistens, suggest a likely evolutionary model of 
the gene coding for CYP116B5. It can be speculated that a horizontal gene transfer 
event mediated by pRHL3 occurred from the donor bacterium R. jostii RHA1 to the 
receiving A. radioresistens S13. This event was followed by gene fusion and a 
subsequent integration of the new fused gene in A. radioresistens chromosome, 
probably as the result of recombination processes. 
 Expression of the CYP116B5 gene in media with alkanes as carbon source  
In order to investigate the induction of the CYP116B5 gene by different alkanes, RT-
PCR experiments were performed on RNA extracted from A. radioresistens S13 
grown in minimal medium with the addition of C14 and C16 (medium length 
alkanes), and C24 and C36 (long-chain alkanes) as the sole energy and carbon source 
and from bacteria grown with sodium acetate (control). Using the cyp116b5 gene 
specific primers an amplified product of the expected size of 500 bp, was obtained on 
RNA extracted from S13 grown with both medium- and long-chain alkanes (Fig. 
4Aiii). No amplified product was obtained from the RNA of bacteria grown with 
sodium acetate or from the RT-negative controls (Fig. 4Aii). An amplified fragment 
of the expected size was also obtained using the A. radioresistens S13 16S rDNA 
specific primers on the RNA of the bacteria grown in the presence of medium- and 
long-chain length alkanes and sodium acetate (Fig. 4Ai). The amplicons obtained with 
 11 
cyp116b5 and 16S rRNA primers were purified and sequenced. A nucleotide 
sequence of about 600 bp was obtained for all PCR products, showing a 100% 
sequence identity to S13 P450 and 16S ribosomal genes of A. radioresistens S13. 
These data suggest that the cyp116b5 gene is indeed induced when the A. 
radioresistens S13 is grown both in medium- and long-chain alkanes. 
Heterologous expression of CYP116B5 and co-expression of Ar-BVMO and 
CYP116B5 genes 
In order to confirm the role of CYP116B5 in the first step of alkane oxidation, E. coli 
BL21 cells that are not able to grow on alkanes, were transformed with the expression 
plasmid pET-CYP116B5. Since pBAD and pT7 are incompatible plasmids, cyp116B5 
coding gene was subloned in the expression vector pET (Novagen). A co-
transformation of E. coli BL21 cells with pET-CYP115B5 and the expression vector 
pT7-Ar-BVMO harboring the A. radioresistens BVMO (Minerdi et al, 2012), was 
also carried out, in order to decipher the functions of the two enzymes in medium- and 
long-chain alkanes oxidation. 
Spectrophotometric evidence for the presence of a P450 enzyme in the cell-free 
extract of both BL21 and TOP10 recombinant cells was obtained from the difference 
spectrum of the reduced and CO-bound form and the oxidised form (Fig. 4B). No 
absorption increase was observed at 450 nm  in the non-transformed cells (data not 
shown).  
The cell cultures containing both the expression vectors were analyzed by SDS-
PAGE. A band at 57 kDa corresponding to the expected Ar-BVMO was detected on a 
Coomassie-stained gel from the cell extract of induced BL21 cells but was not 
observed in the negative control of the same strain harboring pT7-Ar-BVMO whose 
expression was not induced (Fig. 4Bii). Despite the presence of active CYP116B5 as 
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shown in the UV-vis spectrum (Fig. 4Bi) a band corresponding to this enzyme is not 
visible, and this is likely to be due to a low level of expression. 
Heterologous expression proves CYP116B5 is an alkane monooxygenase 
We used a heterologous expression approach to link the cyp116b5 gene to metabolism 
of alkanes. The transformed E. coli BL21 growth on MSM medium supplemented 
with medium-length liquid (C14 and C16) and long-length solid (C24 and C36) 
alkanes was studied in liquid cultures. Growth was measured as an increase in OD600 
for cultures supplemented with liquid alkanes (Fig. 5A), and for cultures 
supplemented with solid alkanes the number of colony-forming units were measured 
on LB agar plates on which 1 ml of liquid culture containing the alkane was plated 
(Fig. 5B). Recombinant E. coli BL21 growth in the presence of C14 and C16 alkanes 
was significantly higher than that measured in control experiments. On the contrary, 
no significant growth was detected when E. coli-pBAD-CYP116B5 was grown on 
minimal medium supplemented with C24 and C36 alkanes (Fig. 5B). This data 
demonstrate that in the case of subterminal oxidation of long-chain alkanes another 
monooxygenase  is required. 
In order to confirm the role of Ar-BVMO in the degradation of long-chain alkanes, E. 
coli BL21 was co-transformed with pET-CYP116B5 and pT7-Ar-BVMO. The growth 
of transformed BL21 cells was tested in MSM medium supplemented with C24 and 
C36 as the sole energy and carbon source. Results showed a significant growth both 
on C24 and C36 alkanes (Fig. 5C). 
Activity of CYP116B5 
The A. radioresistens S13 cytochrome P450 is proposed to be involved in terminal 
oxidation of medium-chain alkanes, and in order to confirm its activity partially 
purified CYP116B5 was incubated with tetradecane at 25°C for 26 hours (Chen et al, 
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2012) and the reaction products were analysed by gas chromatography. Gas 
chromatographic analysis of the reaction products showed a peak corresponding to 
tetradecanol (RT= 19.28 min). This peak was present only in the enzymatic reaction 
and not observed in the control (Fig. 6) demonstrating that the CYP116B5 is indeed 
capable of alkane oxidation. 
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Discussion 
A. radioresistens S13 is capable of growing on minimal medium supplemented with 
medium- and long-chain alkanes, but relatively little is known about the genetic 
characteristics of its alkane-degradative system. We have previously reported the 
presence of almA and alkB genes coding for a BVMO and AlkB hydroxylase, whose 
expression is induced by the presence of long- and medium-chain alkanes in the 
growth medium, respectively (Minerdi et al, 2012). 
Enzymes of the AlkB and CYP153 families are known to catalyze the first step in the 
catabolism of medium-chain length alkanes, as they selectively oxidize the terminal 
carbon to produce the 1-alkanols enabling their host organisms to utilize alkanes as 
carbon sources (Koch et al, 2009). 
Several bacterial strains can assimilate alkanes larger than C20. These strains usually 
contain several alkane hydroxylases. Those active on C10–C20 alkanes are usually 
related to P. putida GPo1 AlkB or to Acinetobacter sp. EB104 cytochrome P450. 
However, the enzymes that oxidize alkanes larger than C20 seem to be rather 
different. Acinetobacter sp. M1, that can grow on C13–C44 alkanes, contains a 
soluble Cu2+ dependent alkane hydroxylase that is active on C10–C30 alkanes. 
Acinetobacter strain DSM 17874 has been found to contain the almA gene that codes 
for a BVMO enzyme capable of oxidizing alkanes from C20 to >C32 in length 
(Throne-Holst et al, 2006). Several bacterial strains can degrade >C20 alkanes using 
enzyme systems that have still not been characterized and that may include new 
proteins unrelated to those currently known. 
The presence of a gene coding for a self-suffcient P450 monooxygenase of class VII 
in the genome of A. radioresistens S13 is surprising because up to now only class I 
P450 enzymes have been identified in Acinetobacter species.  
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The evolutionary model we propose in this paper involves a plasmid-mediated 
horizontal gene transfer from R. jostii to A. radioresistens S13. This event was 
followed by gene fusion and a subsequent integration of the new fused gene in A. 
radioresistens chromosome. Many of these proteins comprise one or several domains. 
Gene fusions characteristically bring together proteins that function in a concerted 
manner, such as successive enzymes in metabolic pathways, enzymes and the 
domains involved in their regulation, or DNA-binding domains and ligand-binding 
domains in prokaryotic transcriptional regulators (Yanai et al, 2001). The selective 
advantage of domain fusion lies in the increased efficiency of coupling of the 
corresponding biochemical reaction or signal transduction step (Marcotte et al, 1999) 
and in the tight co-regulation of expression of the fused domains (Yanai et al, 2001). 
In some cases, the amount and source of horizontal gene transfer can be linked to an 
organism's lifestyle. Horizontal gene transfer has the capability of introducing, 
immediately upon integration, completely novel physiological traits (Koonin et al, 
2001). The Acinetobacter genus has received particular attention because of its 
metabolic versatility and, in the case of clinical isolates, of its multidrug resistance 
pattern (Towner, 2009).  Acinetobacters have the ability to take up extracellular DNA 
from the environment, a mechanism probably used for the acquisition of new 
functions by horizontal gene transfer (Barbe et al, 2004). A. radioresistens S13 was 
isolated from soil surrounding an activated sludge pilot plant for its fast phenol 
catabolism when used as the sole carbon and energy source (Pessione and Giunta, 
1997). According to their capabilities to degrade xenobiotics, A radioresistens and 
Rhodococcus jostii can occupy the same ecological niche, thus it can be assumed that 
S13 CYP116B5 coding gene could be derived from R. jostii by gene fusion and 
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horizontal transfer event leading to the acquisition of new metabolic capabilities such 
as the oxidation of alkanes. 
The cyp116b5 gene is induced by the presence of both medium- and long-chain 
alkanes, while expression of the gene coding for alkane hydroxylase B is induced only 
by the presence of medium-chain alkanes (Minerdi et al, 2012). Some bacterial strains 
contain only one alkane hydroxylase, as is the case for the well-characterized alkane 
degrader P. putida GPo1. Many other strains have several alkane-degradation 
systems, each one being active on alkanes of a certain chain-length or being expressed 
under specific physiological conditions. Alcanivorax borkumensis has two AlkB-like 
alkane hydroxylases and three genes coding for cytochromes P450 believed to be 
involved in alkane oxidation (Schneiker et al, 2006).  In addition, A. borkumensis 
seems to have other uncharacterized genes involved in oxidation of branched alkanes 
and phytane (Schneiker et al, 2006). The substrate range of the A. borkumensis AlkB-
like alkane hydroxylases partially overlaps. AlkB1 oxidizes C5–C12 n-alkanes, while 
AlkB2 is active on C8–C16 n-alkanes (van Beilen et al, 2004). 
Heterologous expression of novel bacterial alkane hydroxylases is complicated when 
there is a three component system where all the components are necessary for enzyme 
activity. Several alkane hydroxylase systems have been expressed heterologously. A 
DNA region of about 35 Kbp containing  alkane hydroxylase system genes from P. 
putida Gpol was cloned into an E. coli strain and into a mutant strain of P. putida 
unable to grow on alkanes. These transformants metabolized n-alkanes as shown by 
mineralization and growth assays (Eggink et al, 1987). Heterologus expression of 
other alkane 1-monooxygenase genes from several bacteria such as Rhodococcus 
strains (Whyte et al, 2002), Alkanicorax borkumensis AP1 (Smits et al, 2002), 
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Prauserella rugosa NRRLB-2295 (Smits et al, 2002) and Mycobacterium 
tuberculosis H37Rv (Smits et al, 2002)  were confirmed using this P. putida system.  
By comparison to all the above-mentioned P450 systems we conclude that 
CYP116B5 from A. radioresistens is a self-sufficient enzyme. Heterologous 
expression of CYP116B5 in E. coli BL21 demonstrated that the bacterium is able to 
grow on minimal medium supplemented with medium chain alkanes but not in the 
presence of long chain alkanes. These data confirm that cytochrome P450 is involved 
in the first step of terminal oxidation of medium-chain alkanes overlapping AlkB and 
in the first step of sub-terminal oxidation of long-chain alkanes. In the case of long 
chain alkanes another monooxygenase is needed for their degradation and bacterial 
growth. Co-expression of both CYP116B5 and BVMO in E. coli allowed the cells to 
grow also with C24 and C36 alkanes, demonstrating that the long-chain alkane 
degradation in A. radioresistens S13 requires the additional activity of the BVMO. 
In conclusion, we found a novel bacterial self-sufficient cytochrome P450 belonging 
to family CYP116 involved in the first steps of alkane oxidation and to our 
knowledge, it is the first enzyme of this class to have its natural substrate and function 
identified. 
 
Experimental procedures 
Bacterial strains and culture media  
Acinetobacter radioresistens S13 was streaked onto Luria–Bertani (LB, 1.0% 
Tryptone 0.5% Yeast Extract 1.0% Sodium Chloride) agar medium and incubated at 
30 °C. For long-term storage, bacterial culture was maintained at -80 °C in liquid LB 
containing 20% glycerol. 
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Escherichia coli strains TOP10 and BL21 (DE3) (Invitrogen, Karlsruhe, Germany) 
for vector propagation and heterologous expression of the recombinant proteins (using 
the pBAD and pT7 vectors) were grown at 37°C in LB medium containing 100 and 
50 µg/ml ampicillin as a selection marker, respectively. In the case of BL21 cells 
transformed with pET-CYP116B5, 30 µg/ml kanamycin was used as the selection 
marker. 
DNA preparation and PCR detection of cytochrome P450 gene 
A. radioresistens S13 was grown on LB medium at 30°C for 24 hours and centrifuged 
for 10 min at 4,000 rpm. The pellet was resuspended in 250 µl of sterile water. This 
suspension was heated at 95°C for 5 min to release the DNA. The heated suspension 
(2 µl) was then used to PCR-amplify the gene coding for cytochrome P450. To 
amplify the genomic sequence of A. radioresistens S13 cytochrome P450 gene, 
primers SK82P450-Forward (5’-TTCCTCGTGAACAGCAACTG-3’) and 
SK82P450-Reverse (5’-GCAGTGCCATATCAGCAAGA-3’) were designed on the 
basis of the P450 gene of A. radioresistens strain SK82 sequence, available in 
databases (ZP_05361336.1). PCR reactions were carried out in a final volume of 20 
µl and containing 0.5 mM of each primer, 2.0 µl of 10x buffer (Qiagen, Hilden, 
Germany), 2.5 mM MgCl2, 250 mM of each dNTP, 2 µl of bacterial lysate preparation 
and 1U of Taq DNA polymerase (Qiagen, Hilden, Germany). The PCR cycling 
conditions were as follows: denaturation at 95°C for 3 min; 30 cycles at 94°C for 45 s, 
55°C for 1 min and 72°C for 1 min; and a final extension at 72°C for 7 min using a 
Techne TC-312 thermal cycler. In order to obtain the full sequence of the gene, a 
genome walking strategy was adopted using primers specifically designed on the 
basis of A. radioresistens SK82 cytochrome P450 flanking gene sequences. 
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PCR product purification, sequencing and gene cloning in expression vector 
The PCR product (about 700 bp) was excised from the gel and purified using the 
QIAquick PCR purification kit (Qiagen, Hilden, Germany). The purified product was 
then directly sequenced without cloning steps by using the PCR primers described 
above. The sequencing processes were conducted with an ABI model 3730 DNA 
sequencer by the Eurofins MWG operon sequencing service (Ebersberg, Germany). 
Two primers (S13P450-Forward: 5’-AAGTTCAGGATGAACGTAAAA-3’; S13-
Reverse: 5’-TCATTTTCCCTGAATTTGTTGTTA-3’) designed at the 5’ and 3’ of 
the sequence were used to amplify the full length S13 P450 gene using the PCR 
conditions described above except for the annealing temperature that was 62°C. 
An amplified fragment of about 2,300 bp was obtained and cloned into pBAD-TOPO 
(Invitrogen) expression vector and subsequently E. coli BL21 were transformed with 
this plasmid. To verify the accuracy of amplification, the plasmid-DNA, propagated 
in E. coli BL21 and isolated with a NucleoSpin Plasmid Kit (Macherey-Nagel), was 
sequenced. Subsequently, for co-expression experiments, the cyp115b5 gene was 
subcloned in the pET30a expression vector (Novagene) using the restiction sites 
EcoR1 and NdeI.  The correct insertion of the ORF was confirmed by  DNA 
sequencing of the entire clone. 
Nucleotide sequence accession number 
The cytochrome P450 gene sequence obtained from A. radioresistens S13 was 
submitted to the GenBank database and assigned the Accession No. AET34456.1. 
Sequence retrieval and alignment 
Amino acid sequences from completely sequenced genomes of proteobacteria were 
retrieved from GenBank database (http://www.ncbi.nlm.nih.gov). BLAST (Altschul et 
al, 1997) probing of database was performed with the BLASTP option of this 
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program using default parameters. Only those sequences retrieved with an E-value 
below the 0.05 threshold were taken into account. Reverse Position-Specific BLAST 
(PSI) algorithm was used to search conserved domains in the A. radioresistens S13 
P450 sequence. 
The ClustalW  (Thompson et al, 1994) program was used to perform pairwise and 
multiple amino acid sequence alignments. Alignments were manually checked and 
mis-aligned regions were removed. 
Phylogenetic analysis  
Phylogenetic analysis was performed using MEGA version 4 (Tamura et al, 2007), 
after multiple sequence alignment and truncation to the same length. Distances 
according to the Kimura two-parameter model (Kimura, 1980) and clustering with the 
neighbor-joining method  (Saitou and Nei, 1987) were determined using bootstrap 
values based on 1,000 replications. 
Growth of A. radioresistens S13 on n-alkanes 
A. radioresistens S13 was grown in LB medium at 37°C on a rotary shaker at 180 rpm 
until growth reached the stationary phase (A600= 3.8-4.0) and transferred to 500 ml 
flasks containing 100 ml of mineral salts medium (MSM) (Sakai et al, 1994). Alkanes 
were added either as 0.35% v/v liquid alkanes (C14 and C16, 99% purity, Sigma 
Aldrich, Italy) (Throne-Holst et al, 2006) or 3 g/l of solid alkanes (C24 and C36, 98% 
o purity, Sigma Aldrich, Italy) as the sole carbon and energy source. Absorbance at 
600 nm was adjusted to 0.1. Flasks were incubated at 30°C in a rotary shaker 
operating at 220 rpm for 7 days. 1 ml samples were taken from each culture at regular 
intervals and were used to measure bacterial growth. For cultures supplemented with 
liquid alkanes, growth was measured spectrophotometrically (Agilent Technologies 
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model 8453E, Santa Clara, USA) at 600 nm using a cuvette with 1 cm path length. All 
the solid alkanes formed small micelles in the liquid medium, which made it 
impossible to accurately measure the OD600. Therefore, growth for cultures 
supplemented with solid alkanes was measured as viable cell count on LB plates at 
30°C. Identical medium and MSM plus sodium acetate (5g/l) as carbon source in 
place of alkanes were used as controls. All experiments were done in triplicates.  
All alkanes of defined chain lengths were purchased from Sigma-Aldrich (Italy). For 
simplicity, alkanes of defined chain lengths are referred to by the number of carbon 
atoms they contain, i.e. tetradecane will be referred to as C14, hexadecane as C16, 
tetracosane as C24 and hexatriacontane as C36 throughout the article. 
Semi-quantitative reverse transcription RT-PCR analyses 
Total RNA for RT-PCR from A. radioresistens S13 grown in the presence of C14, 
C16, C24 and C36 alkanes and sodium acetate added as a control to the minimal 
growth medium was isolated using RNeasy Mini Kit (Qiagen) according to the 
manufacturer's instructions. cDNA was synthesized in a two-step process using 
Superscript II (Invitrogen). The primers used in RT-PCR reactions consisted of the 
following couple specifically designed on the basis of the sequence of A. 
radioresistens S13 P450 gene: S13P450-Forward (5’: 
TGTCTGGCAGTTTGTTCTGG-3’) and S13P450-Reverse (5’: 
ACTACCGCACTAGCCTCTGC-3’). Single-stranded cDNA was obtained with the 
specific antisense primer S13P450-Reverse using total RNA as the template. RNA 
samples were denatured at 65°C for 5 min and then reverse transcribed at 50°C for 1 
hour in a final volume of 20 µl containing 2 µl of total RNA, 1mM each of specific 
primers, 0.5 mM dNTPs, 10U RNase inhibitor, 4 µl buffer (Invitrogen), 2 µl 0.1M 
dithiothreitol and 1 µl of Superscript II (Invitrogen). The absence of undigested 
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genomic DNA was assessed by a control PCR carried out with Platinum Taq DNA 
polymerase (Invitrogen) and the A. radioresistens S13 16S rRNA gene specific 
primers (Minerdi et al, 2012) using the five total RNAs as templates and the PCR 
conditions described above. RT-PCR experiments were conducted using three 
replicates on three independent samples. The amplified products were analyzed by 
1.4% agarose gel electrophoresis in a TAE running buffer (Sambrook et al, 1989).  
Heterologous expression of cytochrome P450 in E. coli BL21 and TOP10 cells 
Expression of A. radioresistens cytochrome P450 (CYP116B5) was achieved starting 
from both a colony of E. coli TOP10 and BL21 transformed with the pBAD-
CYP116B5 (Ampicilline resistant) and pET-CYP116B5 (Kanamycin resistant) 
plasmid respectively, grown overnight in 5 ml of LB with 100 µg/ml of ampicillin and 
30 µg/ml of kanamycin at 37°C. This was used as the inoculum of 500 ml of Terrific 
broth (TB), containing 100 µg/ml of ampicillin. The cultures were grown at 37°C, 
until an optical density at 600 nm of 0.4-0.6 was achieved. At this point protein 
production was induced by the addition of L-arabinose (0.2%) for pBAD-CYP116B5 
and 1mM IPTG in the case of pET-CYP116B5. 0.5 mM δ−aminolevulinic acid (haem 
precursor) and 20 mg/l riboflavin (FMN precursor) were also added. The induced 
cells were then grown for 48 h at 24°C. After this time, the cells were harvested by 
centrifugation at 4,000 rpm for 20 min at 4°C and resuspended in lysis buffer (50 mM 
potassium phosphate pH 7.4 and 0.1 mM phenylmethyl sulfonyl fluoride). Lysozyme 
was added to the suspension at a final concentration of 1 mg/ml and the cell 
suspension was stirred for 30 min at 4°C. Lysis was performed by sonication (5 x 30s 
pulses) on ice with a Misonix Ultrasonic Sonicator (Teltow, Germany). The cell-free 
extracts were obtained by ultracentrifugation at 40,000 rpm for 20 min at 4°C. 
Expression of the A. radioresistens P450 (CYP116B5) was detected by using the 
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supernatant and measuring the formation of the reduced and carbon monoxide bound 
form of the P450 from the difference spectrum obtained at 450 nm using a Hewlett-
Packard 8453 diode array spectrophotometer. 
Co-transformation and co-expression of cytochrome P450 and BVMO in E. coli 
BL21  
E. coli BL21 (DE3) was transformed  with an equal concentration of pET-CYP116B5 
and pT7-Ar-BVMO plasmids (Minerdi et al, 2012). In order to co-express CYP116B5 
and Ar-BVMO a combination of the expression conditions described above and in 
Minerdi et al (2012) was used. After the co-expression the cells were collected by 
centrifugation, one aliquote was used for growth experiments and the other was lysed 
for spectroscopy and SDS-PAGE analysis. 
Expression of the Ar-BVMO gene was detected by analyzing the cell lysate by SDS-
PAGE and comparing the resulting protein banding pattern with that of a negative 
control. In the case of CYP116B5 expression, spectrophotometric analysis of the cell 
lysate upon reduction with sodium dithionite and the subsequent bubbling of carbon 
monoxide was used to obtain a difference spectrum at 450 nm, as mentioned earlier. 
Growth of E. coli BL21 on n-alkanes 
E. coli BL21 cells transformed with pET-CYP116B5 and co-transformed with pET-
CYP116B5/pT7-Ar-BVMO were washed 5 times with MSM medium and were 
transferred to 500 ml flasks containing 100 ml MSM medium with 50 µg/ml of 
ampicillin, 25 µg/ml kanamycin, and 1 mM IPTG. Medium- and long-chain alkanes 
were added in the same conditions described above. Non induced E. coli BL21 cells 
were used as controls. The surfactant Alkanol (Sigma) was added at a concentration 
of 1% v/v. 
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1 ml samples were taken from each culture after 36 hours and were used to measure 
bacterial growth. These experiments were done to investigate the involvement of 
CYP116B5 and Ar-BVMO in the degradation of medium- and long-chain alkanes. 
Partial purification of CYP116B5 
Expression of A. radioresistens CYP116B5 was achieved as described above. The 
bacterial lysate from transformed TOP10 cells was centrifuged at 40,000 rpm for 
20 min at 4°C and then the supernatant was loaded on a DEAE column pre-
equilibrated with buffer A (500 mM Tris-HCl pH 7.2, 1mM EDTA). CYP116B5 was 
eluted using a gradient of 0-500 mM KCl. Eluted fractions that contained the protein 
(peak absorbance at 418 nm) were pooled and loaded on a Q-sepharose column pre-
equilibrated with buffer A. The column was washed extensively with the same buffer 
and CYP116B5 was eluted using a gradient of 0-500 mM KCl. Fractions containing 
CYP116B5 were pooled and buffer exchanged to buffer A by Amicon Ultra 
centrifugal filters (Millipore, Watford, UK). 
Enzyme-tetradecane incubation 
In order to prove that alkanes are substrates of CYP116B5, the partially purified 
enzyme was incubated with the liquid alkane tetradecane for 26 hours at 25°C in 5 ml 
glass vials.   
The concentration of properly folded P450 protein was determined from the CO 
difference spectrum of E. coli extract after sonication, removal of cell debris, and 
bubbling CO into the sample. The reactions were carried out in buffer A containing 
partially purified protein (5 µM). Substrate was added to this solution as 10 µl of 400 
mM total substrate in 1% ethanol. After 1 minute, NADPH was added at a 
concentration of 1.5 mM. Reaction products were extracted by using hexane. The 
tubes were vortexed and then centrifuged at 14,000 rpm for 5 minutes in a 
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microcentrifuge. The hexane layer was removed with a pipette and analyzed by gas 
chromatography to determine product formation. Control reactions were performed by 
repeating these steps in the absence of the enzyme. 
Gas chromatography 
Identification of analytes was performed using tetradecane and tetradecanol standards 
(Sigma). All samples were injected at a volume of 2.0 µl and analyses were performed 
in triplicates. Qualitative analysis of transformation reaction product was performed 
on an Agilent 7890 A gas chromatograph with a flame ionization detector (FID). 
Direct analysis of tetradecane hydroxylation products were performed on a DB-WAX 
capillary column (cross-linked/surface bonded 100% polyethylene glycol, 30 m 
length, 0.32 mm ID, 0.25 mm film thickness) connected to the FID detector. The 
program used for separating the alcohol product was 250°C injector, 250°C detector, 
50°C oven for 2 minutes, followed by 10°C/minute gradient up to 250°C, and finally 
250°C for 3 minutes. 
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Titles and legends to figures 
 
Figure 1 
Phylogenetic relationships within naturally self-sufficient cytochrome P450 enzymes. 
The sequence of CYP116B5 was aligned with class VII cytochrome P450 sequences 
from other bacteria and the un-rooted phylogenetic tree was calculated by using 
CLUSTALW and neighbour-joining method. The numbers at the nodes are the 
bootstrap confidence values obtained after 1000 replicates. The scale bar indicates 
distance in substitutions per nucleotide. The species and proteins are: R. eutropha= 
cytochrome P450 (YP_299468.1) from Ralstonia eutropha JMP134; C. 
metallidurans= cytochrome P450 from Cupriadivus metallidurans (YP_587063.1); V. 
paradoxux= cytochrome P450 from Variovorax paradoxus S110 (YP_002945479.1); 
A. pieachaudii= cytochrome P450 from Achromobacter piechaudii ATCC 43553 
(ZP_ 06690070.1); B. ubonensis= cytochrome P450 from Burkholeria ubonensis 
(ZP_02376798.1); B. thailandensis= cytochrome P450 from Burkholderia 
thailandensis (ZP_438922.1); B. oklahomensis= cytochrome P450 from Burkholderia 
oklahomensis (ZP_02360413.1); C. testosteroni= cytochrome P450 from Comamonas 
testosteroni KF-1 (ZP_ 03546158.1); D. acidovorans= cytochrome P450 from Delftia 
acidovorans SPH-1 (YP_001561718.1); R. equi= cytochrome P450 from 
Rhodococcus equi ATCC 33707 (ZP_ 06830897); R. ruber= cytochrome P450 from 
Rhodococcus ruber (AAY1795001); S. viridis= cytochrome P450 from 
Saccharomonospora viridis DSM 43017 (YP_003132604.1); T. bispora= cytochrome 
P450 from Thermobispora bispora (YP_003651726.1); K. sedentarius= cytochrome 
P450 from Kytococcus sedentarius DSM20547 (YP_003149991.1); S. witchii= 
cytochrome P450 from Sphingomonas witchii RW1 ()YP_001263583.1); S. 
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aggregata= cytochrome P450 from Stappia aggregata AM 12614 (ZP_01549958.1); 
A. radioresistens S13= cytochrome P450 from Acinetobacter radioresistens S13 
(AET34456.1); A. radioresistens  SK82= Cytochrome P450 from Acinetobacter 
radioresistens SK82 (ZP_05361336.1); A. radioresistens SH164= cytochromome 
P450 from Acinetobacter radioresistens SH164 (EEY86620.1). 
 
Figure 2 
A) Aminoacid sequence alignment of the N-terminal portion (residues 1-392) of 
CYP116B5 with those of other P450 enzymes. The conserved oxygen and haem 
binding sites are highlighted in green and red, respectively. The conserved cysteine 
residue that provides the fifth ligand to the haem iron is marked by an asterisk. 
RHERY= thiocarbamate-inducible cytochrome P450 from Rhodococcus erythropolis 
NI86/21 (ZP_04386486.1); BACSUB= cytochrome P450 from Bacillus subtilis 
(AAC00266.1); PSSP= terpene-inducible cytochrome from Pseudomonas spp. 
(AAA25996.1); MYCOTUB= putative cytochrome P450 from Mycobacterium 
tuberculosis (CAA17439.1); ACRAD= cytochrome P450 from A. radioresistens S13 
(AET34456.1). 
B) Aminoacid sequence alignment of the C-terminal portion (residues 444-758) of 
CYP116B5 (ACRAD) with two different dioxygenase reductase subunits. The FMN-
binding motif is highlighted in grey, and the NADH- binding motif is highlighted in 
purple. The four cysteine residues which are involved in binding the iron-sulfur 
cluster are marked with asterisks. POBB= phenoxibenzoate dioxygenase ??subunit 
from Pseudomonas pseudoalcaligenes (Q52186.1); VANB= vanillate O-demethylase 
oxidoreductase from Pseudomonas aeruginosa E2 (EKA50456.1).  
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Figure 3 
Phylogenetic analysis of the N-terminal (A) and C-terminal (B) domain of 
cytochrome P450 of A. radioresistens S13. Neighbor joining tree was built using 
pairwise deletion with p- distance options. The numbers at the nodes are the bootstrap 
confidence values obtained after 1000 replicates. The scale bar indicates distance in 
substitutions per nucleotide. The species and proteins are:  
(A) N-term. A. radioresistens SK82= N-terminal domain of cytochrome P450 class 
VII from Acinetobacter radioresistens SK82 (ZP_05361336.1); N-term. A. 
radioresistens SH164= N-terminal domain of cytochrome P450 class VII from 
Acinetobacter radioresistens SH164 (EEY86620.1); N-term. A. radioresistens S13= 
N-terminal domain of CYP116B5 from Acinetobacter radioresistens S13 
(AET34456.1); CYP116 R. josti RHA1= cytochrome P450 116 class I from 
Rhodococcus jostii RHA1 (YP_709125.1); CYP Roseobacter sp. MED193= 
cytochrome P450 class I from Roseobacter sp. MED193 (ZP_01058383.1); CYP 
Bradyrhizobium sp. BTAi1= cytochrome P450 class I from Bradyrhizobium sp. 
BTAi1 (YP_001237726); CYP C. glutamicum= cytochrome P450 class I from 
Corynebacterium glutamicum AGC13032 (YP_224846); CYP Arthrobacter sp. 
FB24= cytochrome P450 class I (YP_831475.1) from Arthrobacter sp. FB24; 
CYP254 R. jostii RHA1= cytochrome P450 class I from Rhodococcus jostii RHA1 
(ABG92259.1); CYP257 R. jostii RHA1= cytochrome P450 class I from Rhodococcus 
jostii RHA1 (YP_708874.1); CYP C. segnis= cytochrome P450 class I from 
Caulobacter segnis (YP_003594400.1); CYP C. segnis= cytochrome P450 class I 
from Caulobacter segnis (YP_003594400.1); CYP Caulobacter sp. K31= cytochrome 
P450 class I from Caulobacter sp. K31 (YP_001686023,1); CYP153 Acinetobacter 
sp. ADP1: cytochrome P450 class I from Acinetobacter sp. ADP1 (CAG68425.1); 
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CYP111 Acinetobacter sp. OC4= cytochrome P450 class I from Acinetobacter sp. 
OC4  (BAE78452.1); ); CYP153  Acinetobacter sp. EB104= cytochrome P450 class I 
from Acinetobacter sp. EB104 (NP_114222.1); CYP147 R. jostii RHA1= cytochrome 
P450 class I from Rhodococcus jostii RHA1 (ABG94315); CYP256 R. jostii RHA1= 
cytochrome P450 class I from Rhodococcus jostii RHA1 (YP_708186.1). 
(B) oxred R. jostii RHAI= 2Fe2S-oxidoreductase from Rhodococcus jostii RHA1 
(YP_709124.1); oxred Rhodococcus sp. DK17= 2Fe2S, flavodoxin oxidoreductase 
from Rhodococcus sp. DK17 (ABD14375.1); oxred R. opacus B4= 2Fe2S, flavodoxin 
oxidoreductase from Rhodococcus opacus B4 (YP_002778964.1); oxred 116 R. 
jostii= 2Fe2S, flavodoxin 116 from Rhodococcus jostii (YP_709124.1); C-term A. 
radioresistens S13= C-terminal domain of CYP116B5 from Acinetobacter 
radioresistens S13 (AET34456.1); C-term A. radioresistens SH164= C-terminal 
domain of CYP116B5 from Acinetobacter radioresistens SH64 (EEY86620.1); C-
term A. radioresistens SK82= C-terminal domain of CYP116B5 from Acinetobacter 
radioresistens SK82 (ZP_05361336.1); oxred Janthinobacterium sp. Marseille= 
2Fe2S, 2Fe2S, flavodoxin oxidoreductase from Janthinobacterium sp. Marseille 
(YP_001354196.1); oxred D. acidovorans= 2Fe2S, flavodoxin oxidoreductase from 
Delftia acidovorans (YP_001562385.1); oxred C. taiwanensis= 2Fe2S, flavodoxin 
from Cupriavidus taiwanensis (YP_002007256.1); oxred R. euthropha H16= 2Fe2S, 
flavodoxin oxidoreductase from Ralstonia eutropha H16 (YP_728901.1); oxred S. 
japonicum UT26S= 2Fe2S, flavodoxin-oxidoreductase from Sinorhizobium 
japonicum UT26S (YP_003547113.1); oxred Curvibacter sp. = 2Fe2S, flavodoxin 
oxidoreductase from Curvibacter sp. (CBA29570.1); oxred Acinetobacter sp. DR1= 
2Fe2S, flavodoxin oxidoreductase from Acinetobacter sp. DR1 (YP_003731973.1); 
oxred Acinetobacter sp. SH024= 2Fe2S, flavodoxin oxidoreductase from 
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Acinetobacter sp. SH024 (ZP_06690260.1); oxred Acinetobacter sp. RUH2624= 
2Fe2S, flavodoxin oxidoreductase from Acinetobacter sp. RUH2624 
(ZP_05824483.1); oxred  A. baumanni AYE = 2Fe2S, flavodoxin oxidoreductase 
from Acinetobacter baumanni AYE (YP_001713598.1); oxred A. baumanni AB900= 
2Fe2S, flavodoxin oxidoreductase from Acinetobacter baumanni AB900 
(ZP_04663333.1). 
 
Figure 4  
A) Agarose gel of RT-PCR products amplified by using A. radioresistens S13 16S 
rDNA. i): experiment; ii) control without RT and iii) CYP116B5 gene specific 
primers. RNA from S13 grown in minimal medium supplemented with C14 (lane 1), 
C16 (lane 2), C24 (lane 3) and C36 (lane 4) alkane; control experiment of RNA from 
S13 grown in minimal medium supplemented with sodium acetate (lane 5); lane M= 
DNA mass ladder (XL 1 Kb, Eppendorf), lane M’= DNA mass ladder (HyperLadder 
I, Bioline).  
B) i) Difference spectrum in the presence of carbon monoxide for cell-free extract of 
E. coli TOP10-pBAD-CYP116B5 (black dotted line), E. coli BL21-pET-CYP116B5 
(gray dashed line)  and E. coli BL21 co-transformed with pET-CYP116B5 and pT7-
Ar-BVMO (black line).  
(ii) SDS-PAGE  of cell extract showing the expression of the Ar-BVMO gene in co-
transformed E. coli BL21. Lane 1: non induced crude extract; lane 2: purified Ar-
BVMO, lane 3: IPTG induced crude extract. 
 
Figure 5 
Growth of E. coli  BL21-pET-CYP116B5 on n-alkanes.  
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A) Growth curve of non induced BL21 in minimal medium (open square), in minimal 
medium supplemented with C14 (open circle) and C16 (open triangle); E. coli-pBAD-
CYP116B5 in minimal medium (filled circle) supplemented with C14 (filled square) 
and C16 (filled triangle) during the first 36 h.  
B) Viable cell number per millilitre of culture when the bacteria were grown on 
minimal medium supplemented with the solid, long-chain C24 and C36 alkanes after 
3 and 6 days, respectively. CTRL= control experiments bacteria grown on minimal 
medium without n-alkanes.  
C) Growth of E. coli BL21 transformed with pET-CYP116B5 and  pET-
CYP116B5/pT7-Ar-BVMO on n-alkanes. Viable cell number per millilitre of cultures 
of bacteria were grown on minimal medium supplemented with the solid, long-chain 
C24 and C36 alkanes after 3 days. CTRL= control experiments, bacteria grown on 
minimal medium without n-alkanes. 
 
Figure  6 
Gas chromatogram following the incubation of CYP116B5 with tetradecane and 
NADH. Tetradecane RT = 9.14 min.; tetradecanol RT = 19.28 min.  
 
Figure 7 
Proposed pathway for alkane degradation in A. radioresistens S13. 
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                     10        20        30        40        50        60 
                      |         |         |         |         |         | 
RHERY        -------------MTEALIDPVVFNPYDYHFHDDPYPTYKRLREESPLYHNPDVGF---W 
BACSUB       -------------------MTIASSTASSEFLKNPYSFYDTLRAVHPIYKGSFLKYP-GW 
PSSP         --------MDARATIPEHIARTVILPQGYADDEVIYPAFKWLRDEQPLAMAHIEGYDPMW 
MYCOTUB      ----------------------------------------------SVFHAGEANS---- 
ACRAD        MNVKVPMHGQCSFHAELQQKGKNFDMFAVPYQQDPALALKEFRAQLPIFFSEAMGY---W 
 
 
                     70        80        90       100       110       120 
                      |         |         |         |         |         | 
RHERY        ALSRYADVVDGFKDNKRLSSANGVSLDP---------AAYGPHAHYVMSFLAMDD-PRHM 
BACSUB       YVTGYEETAAILKDAR-FKVRTPLPESS---------TKYQDLSHVQNQMMLFQNQPDHR 
PSSP         IATKHADVMQIGKQPGLFSNAEGSEILYDQNNEAFMRSISGGCPHVIDSLTSMDP-PTHT 
MYCOTUB      ------MLAGLLGDSSLLLIDDDVHRDR---------RRLMSPPFHRDAVARQAG-—PIA 
ACRAD        IVTRYEDVKAIFRDPITFSACNALEKLTPSC--PEALKILEKYKYGMNRTLVNEDEPVHM 
 
 
                    130       140       150       160       170       180 
                      |         |         |         |         |         | 
RHERY        RLRQLVSRGFTPRRVAELDGRILELTKQHLIPAL-GAGEFDWITEVAGKLPMDVISELMG 
BACSUB       RLRTLASGAFTPRTTESYQPYIIETVHHLLDQVQ-GKKKMEVISDFAFPLASFVIANIIG 
PSSP         AYRGLTLNWFQPASIRKLEENIRRIAQASVQRLLDFDGECDFMTDCALYYPLHVVMTALG 
MYCOTUB      EIAAANIAGWPMAKAFAVAPKMSEITLEVILRTV-----IGASDPVRLAALRKVMPRLLN 
ACRAD        ERRRALMDAFTPQNLEEHQHFVRELVRKKVDGFI-YKGRADLVQEMLWEIPLMVALHFLG 
 
 
                    190       200       210       220       230       240 
                      |         |         |         |         |         | 
RHERY        VPEPDRAELRRKADLVVHREAG-----------VLDVPQPAVEASISLMGYYKEMIAQRR 
BACSUB       VPEEDREQLKEWAASLIQTIDFT---------RSRKALTEGNIMAVQAMAYFKELIQKRK 
PSSP         VPEDDEPLMLKLTQDFFGVHEPDEQAVAAPRQSADEAARRFHETIATFYDYFNGFTVDRR 
MYCOTUB      VG--PWATLALANPSLLNNRLWS-----------R-LRRRIEEADALLYAEIADRRADPD 
ACRAD        VPEDDMQELRKFAVAHTVNTWGR---------PTLEQQLEVAEGVGQFWEYSGRVLEKMK 
 
 
                    250       260       270       280       290       300 
                      |         |         |         |         |         | 
RHERY        RSRTDD--LTSALLDAEIDGDKLSDQEILGFMFLMVVAGNETTTKLLGNALYWGSHHREQ 
BACSUB       RHPQQD--MISMLLKGREK-DKLTEEEAASTCILLAIAGHETTVNLISNSVLCLLQHPEQ 
PSSP         SCPKDD--VMSLLANSKLDGNYIDDKYINAYYVAIATAGHDTTSSSSGGAIIGLSRNPEQ 
MYCOTUB      LAARTDT-LAMLVRAADEDGRTMTERELRDQLITLLVAGHDTTATGLSWALERLTRHPVT 
ACRAD        NNPEGKGWMYDMIAKNRVMPEVVTDNYLHSMMMAIMVAAHETTALASANALKLLLADRKV 
  
 
                    310       320       330       340       350       360 
                      |         |         |         |         |         | 
RHERY        IAPVLDDPER-----------ASEWVEETLRYDTSSQIVARTSVVDLEYHGRTIPAGEKV 
BACSUB       LLKLRENPDL-----------IGTAVEECLRYESPTQMTARVASEDIDICGVTIRQGEQV 
PSSP         LALAKSDPAL-----------IPRLVDEAVRWTAPVKSFMRTALADTEVRGQNIKRGDRI 
MYCOTUB      LAKAVQAADASAAGDPAGDEYLDAVAKETLRIRPVVYDVGRVLTEAVEVAGYRLPAGVMV 
ACRAD        WKKICDNPQL-----------IPGAVEECLRHSGSVVAWRRQVTTESEVSGVKFRKGDKL 
 
 
                    370       380       390       400       410       420 
                      |         |         |         |         |         | 
RHERY        LLLIGSANRDADVFDDADSFQIGRSSSGKLAS-----FGGGVHFCLGAHLAKLEAKIALA 
BACSUB       YLLLGAANRDPSIFTNPDVFDITRSPNPHLS------FGHGHHVCLGSSLARLEAQIAIN 
PSSP         MLSYPSANRDEEVFSNPDEFDITRFPNRHLG------FGWGAHMCLGQHLAKLEMKIFFE 
MYCOTUB      VPAIGLVHASAQLYPDPERFDPDRMVGATLSPTTWLPFGGGNRRCLGATFAMVEMRVVLR 
ACRAD        FLVSASANHDELHFENADELDIYRDNAIEHLT-----FGYGAHQCMGKNIGRMEMCIFIE 
                                                  ≈≈≈≈≈≈≈*≈≈ 
 
 
 
 
RHERY        EFG   
BACSUB       TLL  
PSSP         ELL  
MYCOTUB      EIL  
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                     453       463       473       483       493       503 
                      |         |         |         |         |         | 
POBB         MSAAATMAPVSLRIHAIAYGADDVLLFDLRAPARDGLAPFDAGAHIDLRLPRGITRSYSL 
VANB         --------MIEVIISAMRLVAQDIISLEFVRADGGLLPPVEAGAHVDVHLPGGLIRQYSL 
ACRAD        ----LKAMTRPVRVQAVYPEAEDIIRIELAAIHGEELPRWSAGSHIELVLPNGLSRKYSL 
 
                     513       523       533       543       553       563 
                      |         |         |         |         |         | 
POBB         LNDPAERHRYVIGVKREPESRGGSAWLHADARVGALIEVDGPSNHFALDESAPHAVFIAG 
VANB         WNQPGVQSHYCIGVLKDPASRGGSKAVHENLRVGMRVQISEPRNLFPLEEGVERSLLFAG 
ACRAD        CG-LATDQFYTIAVKREPVSRGGSQWIHQYLKAGEQIYIKGPKNFFKLNLQASQYVLIAG 
                                                                        
                     573       583       593       603       613       623 
                      |         |         |         |         |         | 
POBB         GIGITPLWSMVQRLEHLGTPWTLHYRARSRRGAALLD--ELAGHGDRVHLSFSD-EGAPS 
VANB         GIGITPILCMAQELAAREQDFELHYCARSADRAAFVEWLKVCDFADHVRFHFDNGPDQQK 
ACRAD        GIGITPILSMANSLREQGRPYWLIYLSRQRASMALLK--EVAAHGSAAELYISS--EGKR 
             ====== 
                     633       643       653       663       673       673 
                      |         |         |         |         |         | 
POBB         LDLAAIVAAAPEGAHFYCCGP-VPMLEAFEAAC-VGLDPARVHLEYFAAK---EAPATEG 
VANB         LNAAALLAAEAEGTHLYVCGPGGFMGHVLDTAKEQGWADNRLHREYFAAAP--KVSADDG 
ACRAD        IDLQQLLSALPAGTQVCACGP-EALLDTLTNYI-EDLSQVQLTVEHFGSGKNLFLYENDT 
 
                     683       693       703       713       723       733 
                      |         |         |         |         |         | 
POBB         GFVVHLARSGRTIPIAAGCTILDALQAGGVAVPSSCQQGVCGICETAVLAGVPDHRDLVL 
VANB         SFEVRIHSTGQVLQVPADQTVSQVLDEAGIIVPVSCEQGICGTCITRVVDGEPDHRDFFL 
ACRAD        DFEVELLDSGLTLTVARDQTLLDCLLDKGIDVSFDCTEGLCGSCQLPVEEGEIDHRDKVL 
                               *    *  *    
 
                     743       753 
                      |         | 
POBB         SDQERAAGRTMMICCSGSKTAELTLDL 
VANB         TDAEKAKNDQFTPCCSRAKSACLVLDL 
ACRAD        TRAERDGMKSVISCCSRGK-GKLKLKL 
                    * 
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